South America Nuclear Medicine Radioisotopes Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Nuclear medicine uses radiation to provide information about the functioning of a person’s specific organs or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient’s illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed.

South America Nuclear Medicine Radioisotopes Market Segments Size & Growth:

South America nuclear medicine radioisotopes market is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include growing patient awareness, increasing SPECT and PET applications, development of better instruments and rising incidences of cancer and cardiac disorders. However, Reimbursement Problems and Strict Regulatory Issues are thereby hampering the market growth.

South America Nuclear Medicine Radioisotopes Market Segments Share:

South America nuclear medicine radioisotopes market is categorized into the type of radioisotopes which comprise of Iridium, Palladium, Iodine, Technetium, Cesium, and Others. Among them, Technetium holds the largest share in the market. On basis of Applications, the market is segmented into Neurology, Thyroid, Lymphoma, and Others. On the basis of Geography, Brazil is expected to dominate the market with the largest share and the growth in the South America economies is mainly attributed because of huge profit margins and growth prospects.

South America Nuclear Medicine Radioisotopes Market Trends:

• Nuclear medicine has grown because of advances in technology, including hybrid imaging, the introduction of new radiopharmaceuticals for diagnosis and therapy, and the development of molecular imaging based on the tracer principle, which is not based on radioisotopes.
• GE Healthcare has entered into a strategic, long-term partnership with Roche to develop and co-market digital clinical decision support solutions jointly.

South America Nuclear Medicine Radioisotopes Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

• GE Healthcare
• Hologic Inc.
• Medix Inc.
• Segami Corporation
• Positron Corporation